{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:18:06Z","timestamp":1791249486879,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.leukres.2009.01.017","type":"journal-article","created":{"date-parts":[[2009,2,22]],"date-time":"2009-02-22T06:27:36Z","timestamp":1235284056000},"page":"1212-1216","source":"Crossref","is-referenced-by-count":120,"title":["CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia"],"prefix":"10.1016","volume":"33","author":[{"given":"Giuseppe A.","family":"Palumbo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nunziatina","family":"Parrinello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovannella","family":"Fargione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"Cardillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Chiarenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Berretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concetta","family":"Conticello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loredana","family":"Villari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Di Raimondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2009.01.017_bib1","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1136\/jcp.42.6.567","article-title":"Proposals for the classification of chronic (mature) B and T lymphoid leukaemias French-American-British (FAB) Cooperative Group","volume":"42","author":"Bennett","year":"1989","journal-title":"J Clin Pathol"},{"issue":"Suppl. 1","key":"10.1016\/j.leukres.2009.01.017_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1023\/A:1008383406103","article-title":"Lymphoma classification\u2014from controversy to consensus: the R E. A. L. and WHO classification of lymphoid neoplasms","volume":"11","author":"Harris","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1016\/j.leukres.2009.01.017_bib3","first-page":"326","article-title":"Distinction between small lymphocytic and mantle cell lymphoma by immunoreactivity for CD23","volume":"7","author":"Dorfman","year":"1994","journal-title":"Mod Pathol"},{"key":"10.1016\/j.leukres.2009.01.017_bib4","first-page":"818","article-title":"CD23 expression in transformed small lymphocytic lymphomas\/chronic lymphocytic leukemias and blastic transformations of mantle cell lymphoma","volume":"10","author":"Dunphy","year":"1997","journal-title":"Mod Pathol"},{"key":"10.1016\/j.leukres.2009.01.017_bib5","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1309\/UQ4N-M5KL-0ANY-YD3G","article-title":"Value of CD23 determination by flow cytometry in differentiating mantle cell lymphoma from chronic lymphocytic leukemia\/small lymphocytic lymphoma","volume":"116","author":"Gong","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.leukres.2009.01.017_bib6","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1309\/XV4AG7EMWQU7ER67","article-title":"CD23 expression in mantle cell lymphoma: clinicopathologic features of 18 cases","volume":"120","author":"Schlette","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.leukres.2009.01.017_bib7","doi-asserted-by":"crossref","DOI":"10.1007\/s12032-007-9038-7","article-title":"Analysis of CD23 antigen expression in B-chronic lymphocytic leukaemia and its correlation with clinical parameters","author":"Jurisic","year":"2008","journal-title":"Med Oncol"},{"key":"10.1016\/j.leukres.2009.01.017_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/hon.855","article-title":"The cut-off levels of CD23 expression in the differential diagnosis of MCL and CLL","author":"Barna","year":"2008","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.leukres.2009.01.017_bib9","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/cncr.10401","article-title":"The clinical and diagnostic relevance of CD23 expression in the chronic lymphoproliferative disease","volume":"94","author":"DiRaimondo","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2009.01.017_bib10","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/jcp.55.12.940","article-title":"Detection of cyclin D1 in B cell lymphoproliferative disorders by flow cytometry","volume":"55","author":"Jain","year":"2002","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.leukres.2009.01.017_bib11","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1182\/blood-2005-04-1753","article-title":"Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling","volume":"106","author":"Fu","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.01.017_bib12","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1535-6108(03)00028-X","article-title":"The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma","volume":"3","author":"Rosenwald","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.leukres.2009.01.017_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00022744-200003000-00001","article-title":"Classification of small B-cell lymphoid neoplasms using a paraffin section immunohistochemical panel","volume":"8","author":"Chen","year":"2000","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.leukres.2009.01.017_bib14","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1309\/NR8HN08GDPVEMU08","article-title":"Rabbit monoclonal antibodies: a comparative study between a novel category of immunoreagents and the corresponding mouse monoclonal antibodies","volume":"124","author":"Rossi","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.leukres.2009.01.017_bib15","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/(SICI)1097-0142(19980201)82:3<567::AID-CNCR20>3.0.CO;2-Z","article-title":"Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors","volume":"82","author":"Bosch","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2009.01.017_bib16","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/gcc.2870050210","article-title":"Translocation t(11;14)(q13;q32) in chronic lymphoid disorders","volume":"5","author":"Brito-Babapulle","year":"1992","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.leukres.2009.01.017_bib17","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2141.1995.tb05167.x","article-title":"Atypical chronic lymphocytic leukaemia with t(11;14)(q13;q32): karyotype evolution and prolymphocytic transformation","volume":"90","author":"Cuneo","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2009.01.017_bib18","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/00000478-199605000-00009","article-title":"The morphologic spectrum of non-Hodgkin's lymphomas with BCL1\/cyclin D1 gene rearrangements","volume":"20","author":"Swerdlow","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.leukres.2009.01.017_bib19","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.4049\/jimmunol.178.9.5595","article-title":"CD200 expression on tumor cells suppresses antitumor immunity: new approaches to cancer immunotherapy","volume":"178","author":"Kretz-Rommel","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.leukres.2009.01.017_bib20","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF00404426","article-title":"Characterization of the human homolog of the rat MRC OX-2 membrane glycoprotein","volume":"25","author":"McCaughan","year":"1987","journal-title":"Immunogenetics"},{"key":"10.1016\/j.leukres.2009.01.017_bib21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF00364281","article-title":"The gene for MRC OX-2 membrane glycoprotein is localized on human chromosome 3","volume":"25","author":"McCaughan","year":"1987","journal-title":"Immunogenetics"},{"key":"10.1016\/j.leukres.2009.01.017_bib22","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1046\/j.1365-2567.2001.01163.x","article-title":"The unusual distribution of the neuronal\/lymphoid cell surface CD200 (OX2) glycoprotein is conserved in humans","volume":"102","author":"Wright","year":"2001","journal-title":"Immunology"},{"key":"10.1016\/j.leukres.2009.01.017_bib23","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1182\/blood-2006-06-029355","article-title":"CD200 is a new prognostic factor in multiple myeloma","volume":"108","author":"Moreaux","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.01.017_bib24","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/sj.leu.2404559","article-title":"CD200 as a prognostic factor in acute myeloid leukaemia","volume":"21","author":"Tonks","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2009.01.017_bib25","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.bbrc.2007.11.103","article-title":"CD200: a putative therapeutic target in cancer","volume":"366","author":"Moreaux","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.leukres.2009.01.017_bib26","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1126\/science.290.5497.1768","article-title":"Down-regulation of the macrophage lineage through interaction with OX2 (CD200)","volume":"290","author":"Hoek","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.leukres.2009.01.017_bib27","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1615\/CritRevImmunol.v26.i3.20","article-title":"Is the CD200\/CD200 receptor interaction more than just a myeloid cell inhibitory signal?","volume":"26","author":"Minas","year":"2006","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.leukres.2009.01.017_bib28","first-page":"1640","article-title":"The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL","volume":"8","author":"Matutes","year":"1994","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2009.01.017_bib29","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/ajcp\/108.4.378","article-title":"Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b)","volume":"108","author":"Moreau","year":"1997","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.leukres.2009.01.017_bib30","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1182\/blood.V98.1.181","article-title":"CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia","volume":"98","author":"Ibrahim","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.01.017_bib31","doi-asserted-by":"crossref","first-page":"42","DOI":"10.5858\/2003-127-42-FCAOA","article-title":"Flow cytometric analysis of acute leukemias Diagnostic utility and critical analysis of data","volume":"127","author":"Kaleem","year":"2003","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.leukres.2009.01.017_bib32","first-page":"3922","article-title":"CD200 is induced by ERK and is a potential therapeutic target in melanoma","volume":"117","author":"Petermann","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.leukres.2009.01.017_bib33","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1158\/0008-5472.CAN-06-3311","article-title":"Lack of extracellular signal-regulated kinase mitogen-activated protein kinase signaling shows a new type of melanoma","volume":"67","author":"Shields","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2009.01.017_bib34","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.bcp.2006.10.012","article-title":"Pharmacological inhibition of the MAPK\/ERK pathway increases sensitivity to 2-chloro-2\u2032-deoxyadenosine (CdA) in the B-cell leukemia cell line EHEB","volume":"73","author":"Smal","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.leukres.2009.01.017_bib35","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1182\/blood-2007-05-089037","article-title":"The Akt\/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cells","volume":"111","author":"Longo","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.01.017_bib36","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1182\/blood-2004-10-3999","article-title":"Proteomic analysis of mantle-cell lymphoma by protein microarray","volume":"105","author":"Ghobrial","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.01.017_bib37","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nrc2230","article-title":"Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics","volume":"7","author":"Jares","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.leukres.2009.01.017_bib38","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1200\/JCO.1994.12.4.876","article-title":"Mantle cell lymphoma","volume":"12","author":"Harris","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2009.01.017_bib39","doi-asserted-by":"crossref","first-page":"699","DOI":"10.4049\/jimmunol.180.2.699","article-title":"Blockade of CD200 in the presence or absence of antibody effector function: implications for anti-CD200 therapy","volume":"180","author":"Kretz-Rommel","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.leukres.2009.01.017_bib40","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1517\/14712598.8.1.5","article-title":"Rationale for anti-CD200 immunotherapy in B-CLL and other hematologic malignancies: new concepts in blocking immune suppression","volume":"8","author":"Kretz-Rommel","year":"2008","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.leukres.2009.01.017_bib41","first-page":"483","article-title":"CD200 and its receptors as targets for immunoregulation","volume":"6","author":"Gorczynski","year":"2005","journal-title":"Curr Opin Investig Drugs"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212609000228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212609000228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,2]],"date-time":"2021-10-02T05:10:17Z","timestamp":1633151417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212609000228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":41,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0145212609000228"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2009.01.017","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}